Inventor · disambiguated record
Ruben Tommasi
Also filed as: TOMMASI RUBEN · TOMMASI RUBEN A · TOMMASI RUBEN ALBERTO
19 granted patents·7 pending applications·217 citations·filing 1994–2018
94Inventor score
Top patents by PatentIndex Score
26 records- 0191US6353017B1Dipeptide nitrilesNOVARTIS AG·Filed 2000·Granted Mar 5, 2002·52 cites·22 claims
- 0290US5852195APyranone compounds useful to treat retroviral infectionsUPJOHN CO·Filed 1995·Granted Dec 22, 1998·48 cites·5 claims
- 0387US6289914B1Microflow splitterNOVARTIS AG·Filed 2000·Granted Sep 18, 2001·35 cites·19 claims
- 0484US6812237B2N-substituted peptidyl nitriles as cysteine cathepsin inhibitorsNOVARTIS AG·Filed 2001·Granted Nov 2, 2004·15 cites·16 claims
- 0583US10800778B2Beta-lactamase inhibitor compoundsENTASIS THERAPEUTICS LTD·Filed 2017·Granted Oct 13, 2020·4 cites·25 claims
- 0681US9968593B2Combination therapy for treatment of resistant bacterial infectionsENTASIS THERAPEUTICS LTD·Filed 2015·Granted May 15, 2018·4 cites·8 claims
- 0780US10376499B2Combination therapy for treatment of resistant bacterial infectionsENTASIS THERAPEUTICS LTD·Filed 2018·Granted Aug 13, 2019·3 cites·9 claims
- 0876US8362063B2Arylsulfonamide based matrix metalloprotease inhibitorsNOVARTIS AG·Filed 2012·Granted Jan 29, 2013·2 cites·6 claims
- 0974US6169181B1Compounds useful to treat retroviral infectionsUPJOHN CO·Filed 1998·Granted Jan 2, 2001·33 cites·12 claims
- 1068US5977169ASubstituted tetronic acids useful for treating HIV and other retrovirusesFiled 1994·Granted Nov 2, 1999·14 cites·25 claims
- 1164US9822092B2ArylSulfonamide-based matrix metalloprotease inhibitorsNOVARTIS AG·Filed 2014·Granted Nov 21, 2017·0 cites·15 claims
- 1263US8476286B2Quinazoline derivatives which promote the release of parathyroid hormoneBEERLI RENE·Filed 2002·Granted Jul 2, 2013·5 cites·3 claims
- 1360US8975439B2Arylsulfonamide based matrix metalloprotease inhibitorsNOVARTIS AG·Filed 2012·Granted Mar 10, 2015·0 cites·7 claims
- 1460US8222424B2Arylsulfonamide-based matrix metalloprotease inhibitorsEHRHARDT CLAUS·Filed 2009·Granted Jul 17, 2012·0 cites·6 claims
- 1557US2008027060A1Dipeptide nitrilesALTMANN EVA·Filed 2007·Application pending·0 cites
- 1653US2011112076A1Selective hydroxamic acid based mmp-12 and mmp-13 inhibitorsMCQUIRE LESLIE WIGHTON·Filed 2009·Application pending·0 cites
- 1752US2004110806A1Dipeptide derivativesFiled 2003·Application pending·0 cites
- 1851US2007060569A1Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitorsFUJIMOTO ROGER A·Filed 2006·Application pending·0 cites
- 1951US2009197856A1Antiviral compoundsNOVARTIS AG·Filed 2008·Application pending·0 cites
- 2050US2004029814A1Dipeptide nitrilesFiled 2003·Application pending·0 cites
- 2146US8232427B2Selective hydroxamate based MMP inhibitorsLEUTERT THOMAS·Filed 2007·Granted Jul 31, 2012·0 cites·12 claims
- 2245US8841291B2Selective hydroxamic acid based MMP-12 and MMP-13 inhibitorsMCQUIRE LESLIE WIGHTON·Filed 2013·Granted Sep 23, 2014·0 cites·2 claims
- 2345US2004235896A1Certain azacycloalkyl substituted acetic acid derivativesFiled 2002·Application pending·0 cites
- 2441US6060600ASubstituted tetronic acids useful for treating HIV and other retrovirusesUPJOHN CO·Filed 1996·Granted May 9, 2000·2 cites·7 claims
- 2540US8314148B2Selective hydroxamate based MMP inhibitorsLEUTERT THOMAS·Filed 2012·Granted Nov 20, 2012·0 cites·16 claims
- 2633US11046694B2Compounds and methods for treating bacterial infectionsENTASIS THERAPEUTICS INC·Filed 2018·Granted Jun 29, 2021·0 cites·26 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →